CTOs on the Move

Menlo Therapeutics

www.menlotherapeutics.com

 
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Solomon Wang
Director of Information Technology Profile

Funding

Menlo Therapeutics raised $50M on 07/18/2017

Similar Companies

PaxeraMed

PaxeraMed Corp. is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Brooklyn Manor Home for Adults

Brooklyn Manor Home for Adults is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Feinstein Kean Healthcare

Feinstein Kean Healthcare is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cambridge, MA. To find more information about Feinstein Kean Healthcare, please visit www.fkhealth.com

ENV Services

ENV Services is a Hatfield, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Association of Nuerological Surgeons

American Association of Nuerological Surgeons is a Rolling Meadows, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.